CARLSBAD, Calif & AMSTERDAM–(BUSINESS WIRE)– The twelfth annual BIO-Europe Spring(R) international partnering
conference wrapped up in Amsterdam, The Netherlands, last week with
2,500 attendees from the life sciences who engaged in 14,500 one-to-one
partnering meetings vying for 3,609 licensing opportunities on offer.
The event welcomed 1,426 companies overall, including over 250 delegates
The event was produced by EBD Group in conjunction with our national
partner, Health~Holland, representing the Dutch Top Sector Life Sciences
& Health, and supported by HollandBIO and the Netherlands Foreign
Investment Agency (NFIA).
« We are very pleased at the success of BIO-Europe Spring in Amsterdam in
facilitating valuable deals among biotech, pharma and investment
executives toward the development of therapies and cures, » said Anna
Chrisman, Managing Director of EBD Group and KNect365 Life Sciences. « We
look forward to another great event in Vienna in 2019. »
BIO-Europe Spring is the most significant industry event of the new year
where top life science executives come together to access hundreds of
potential partners to make their companies’ collaborative goals a
Hans Schikan, Chairman a.i. of the Top Sector Life Sciences & Health
said, « We were most pleased to welcome BIO-Europe Spring 2018 to the
Netherlands. Hosting this important partnering conference in Amsterdam
not only reflects our leading position, it will gain momentum for
further growth too. »
The event program highlighted cross-border partnerships, the favorable
biotech climate in China, the growing importance of patient engagement
and alternative financing, advances in immuno-oncology, vaccines, and
neurodegeneration therapies, as well as full afternoon sessions on cell
and gene therapy developments and a host of innovative biotech startup
presentations. Look for detailed coverage soon on Partnering Insight.
BIO-Europe Spring 2019 will be held in Vienna, Austria, March 25-27,
2019, and is hosted by LISAvienna. This is a joint life science platform
operated by the Vienna Business Agency and Austria Wirtschaftsservice on
behalf of the Austrian Federal Ministry for Digital and Economic Affairs
and the City of Vienna.
« We are very excited to be working with EBD Group to bring their
springtime flagship event to Vienna, » said Eva Czernohorszky, the Vienna
Business Agency’s representative at LISAvienna. « Vienna is a great place
for top-notch international events and has a diverse biotech ecosystem.
We offer 360 support for innovative startups. »
« Austria is a life science hub due to excellent research, more than 800
life science companies and a perfect central European location. We are
particularly strong in eHealth, immunology, industrial biotech, medical
imaging and oncology, » said Johannes Sarx, the Austria
Wirtschaftsservice’s representative at LISAvienna.
For continuing news coverage about BIO-Europe Spring, including video
interviews and articles on life science dealmaking, go to Partnering
Insight or follow the conference hashtag #BIOEuropeSpring on Twitter.
# # #
About EBD Group
EBD Group’s overriding mission is to help collaborations get started
across the life science value chain. Our range of partnering conferences
has grown to become the largest and most productive conference platform
in the industry. Each one of our six landmark events held in key life
science markets around the world is powered by our state-of-the-art
partnering software, partneringONE(R), that enables delegates to
efficiently identify and engage with new opportunities via one-to-one
Today these events annually attract more than 12,000 senior life science
executives who engage in over 48,000 one-to-one partnering meetings.
These vital one-to-one engagements are the wellspring of deals that
drive innovation in our industry. Our annual events are: BIO-Europe(R),
BIO-Europe Spring(R), ChinaBio(R) Partnering Forum, BioEquity Europe,
BioPharma America(TM), and Biotech Showcase(TM).
Tune into EBD Group’s Partnering Insight for timely coverage of news
that influences the business strategies of the life science industry.
For more information please visit ebdgroup.com.
Source: EBD Group